Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and Psychopathology

NCT02808533 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT02808533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and Psychopathology
Lead sponsor
Centre for Addiction and Mental Health
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2016
Completion date
August 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, schizoaffective disorder